103 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06921 | Ocellatin-3N | GIFDVLKNLAKGVITSLAS | Leptodactylus nesiotus | Not available | CellTiter-Glo assay | A-549 | Lung Cancer | LC50 = 35 ± 1 μM |
| dbacp06922 | Ocellatin-3N | GIFDVLKNLAKGVITSLAS | Leptodactylus nesiotus | Not available | CellTiter-Glo assay | MDA-MB-231 | Breast Cancer | LC50 = 51 ± 16 μM |
| dbacp06923 | Ocellatin-3N | GIFDVLKNLAKGVITSLAS | Leptodactylus nesiotus | Not available | CellTiter-Glo assay | HT-29 | Colorectal Cancer | LC50 = 69 ± 10 μM |
| dbacp06924 | #2(D33-N52) | RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-B |
| dbacp06925 | #2(D33-N52) | RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | MCF-7 | Breast Cancer | Graph figure 1-B |
| dbacp06926 | #5(D93-F112) | RRRRRRRRGGDQEIKFKVETLECREMWKGF | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-B |
| dbacp06927 | #6(M108-L127) | RRRRRRRRGGMWKGFILTVVELRVPTDLTL | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-B |
| dbacp06928 | #6(M108-L127) | RRRRRRRRGGMWKGFILTVVELRVPTDLTL | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | MCF-7 | Breast Cancer | Graph figure 1-B |
| dbacp06929 | 2A(F39-Q58) | RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-C |
| dbacp06930 | 2C(Q44-Q58) | RRRRRRRRGGQGLTIYFYNSNRDFQ | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-C |
| dbacp06931 | 2D(Q44-R55) | RRRRRRRRGGQGLTIYFYNSNR | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-C |
| dbacp06932 | 2D2(Q44-Y51) | RRRRRRRRGGQGLTIYFY | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-C |
| dbacp06933 | 2D3(G45-N52) | RRRRRRRRGGGLTIYFYN | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-C |
| dbacp06934 | 2D5(G45-Y51) | RRRRRRRRGGGLTIYFY | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | IC50 = 19.4 μM |
| dbacp06935 | 6E(V116-M135) | RRRRRRRRGGVVELRVPTDLTLLPGHLYMM | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-D |
| dbacp06936 | 6F (I113-P122) | RRRRRRRRGGILTVVELRVP | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-D |
| dbacp06937 | TAT-2D5 | GRKKRRQRRRPPQGGLTIYFY | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-G |
| dbacp06938 | HTLV-II-Rex-2D5 | TRRQRTRRARRNRGGLTIYFY | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-G |
| dbacp06939 | FHV-2D5 | RRRRNRTRRNRRRVRGGLTIYFY | STAP-2 PH domain–derived peptide | Inhibition of cell signalling | CellTiter-Glo assay | DU-145 | Liver Cancer | Graph figure 1-G |
| dbacp08169 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08170 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 = 6.2 µM |
| dbacp08171 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08172 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 5.4 µM |
| dbacp08173 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08174 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 = 2.6 µM |
| dbacp08175 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 = 7.3 µM |
| dbacp08176 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 = 3.0 µM |
| dbacp08177 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | PC-3 | Prostate Cancer | Not Available |
| dbacp08178 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-549 | Lung Cancer | Not Available |
| dbacp08179 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | NCI-H69 | Lung Cancer | Not Available |
| dbacp08180 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | RL | Lymphoma Cancer | Not Available |
| dbacp08181 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 = 2.6 µM |
| dbacp08182 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 = 7.0 µM |
| dbacp08183 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 = 6.0 µM |
| dbacp08184 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.6 µM |
| dbacp08185 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 6.4 µM |
| dbacp08186 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 = 6.4 µM |
| dbacp08187 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 = 5.0 µM |
| dbacp08188 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 = 5.6 µM |
| dbacp08189 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 = 5.9 µM |
| dbacp08190 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 = 4.6 µM |
| dbacp08191 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 = 5.4 µM |
| dbacp08192 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 3.2 µM |
| dbacp08193 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 6.2 µM |
| dbacp08194 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 = 3.1 µM |
| dbacp08195 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 = 3.6 µM |
| dbacp08196 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 = 4.7 µM |
| dbacp08197 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 = 2.7 µM |
| dbacp08198 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 = 3.0 µM |
| dbacp08199 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 = 2.3 µM |
| dbacp08200 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.4 µM |
| dbacp08201 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 2.6 µM |
| dbacp08202 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 = 1.9 µM |
| dbacp08203 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 = 4.4 µM |
| dbacp08204 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 = 2.1 µM |
| dbacp08205 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08206 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 > 7.5 µM |
| dbacp08207 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08208 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08209 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08210 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 > 7.5 µM |
| dbacp08211 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08212 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 > 7.5 µM |
| dbacp08213 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08214 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 > 7.5 µM |
| dbacp08215 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08216 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08217 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08218 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 > 7.5 µM |
| dbacp08219 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08220 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 > 7.5 µM |
| dbacp08221 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08222 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 > 7.5 µM |
| dbacp08223 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08224 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08225 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08226 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 > 7.5 µM |
| dbacp08227 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08228 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 > 7.5 µM |
| dbacp08229 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08230 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 > 7.5 µM |
| dbacp08231 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08232 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08233 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08234 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 > 7.5 µM |
| dbacp08235 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08236 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 > 7.5 µM |
| dbacp08237 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08238 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 > 7.5 µM |
| dbacp08239 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08240 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08241 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08242 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 > 7.5 µM |
| dbacp08243 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08244 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 > 7.5 µM |
| dbacp08245 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | CPFAC-1 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08246 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | MCF-7 | Breast Cancer | IC50 = 7.3 µM |
| dbacp08247 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | IGROV-1 | Ovarian Cancer | IC50 > 7.5 µM |
| dbacp08248 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.7 µM |
| dbacp08249 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08250 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | UACC-62 | Skin Cancer | IC50 = 6.4 µM |
| dbacp08251 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | MiaPaCa.2 | Pancreatic Cancer | IC50 > 7.5 µM |
| dbacp08252 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | A-498 | Renal Cancer | IC50 = 4.2 µM |